Antibodies specific to prolactin receptor and therapeutic uses thereof

TW202639596APending Publication Date: 2026-10-01ABSCI CORPORATION
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114148189
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-11-06
Filing Date
2025-12-09
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078732_001
    Figure TWG2TA001078732_001
  • Figure TWG2TA001078732_002
    Figure TWG2TA001078732_002
  • Figure TWG2TA001078732_003
    Figure TWG2TA001078732_003
Patent Text Reader

Abstract

The present disclosure provides antibodies that bind to the prolactin receptor (PRLR), nucleic acids encoding the antibodies, methods of production using host cells, and its applications, including applications in pharmaceutical compositions for the treatment of PRLR-associated diseases.
Need to check novelty before this filing date? Find Prior Art